Similar articles

• The influence of injection of 5,6-dihydroxytryptamine to the dorsal raphe nucleus on carbachol-induced defensive behavior and regional brain amine content in the cat.

  Romaniuk A, Filipczak M, Fryczak J. Romaniuk A, et al. Pol J Pharmacol Pharm. 1987 Jan-Feb;39(1):17-25. Pol J Pharmacol Pharm. 1987. PMID: 2444950
• Effects of compounds structurally related to 5,6-dihydroxytryptamine on behavior and brain biogenic amines in the rat.

  Donelson AC, Manian AA, Maickel RP. Donelson AC, et al. Res Commun Chem Pathol Pharmacol. 1982 Dec;38(3):517-20. Res Commun Chem Pathol Pharmacol. 1982. PMID: 7163644
• The effects of intraventricular 6-hydroxydopamine and 5,6-dihydroxytryptamine on morphine induced locomotor stimulation.

  Slater P, Blundell C. Slater P, et al. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jul;312(3):219-24. doi: 10.1007/BF00499149. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 7402365 No abstract available.
• Special chemistry of the basal ganglia I. Monoamines.

  Lloyd KG. Lloyd KG. Pharmacol Ther B. 1975;1(1):49-61. doi: 10.1016/0306-039x(75)90015-x. Pharmacol Ther B. 1975. PMID: 817320 Review. No abstract available.
• Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.

  Ridges AP. Ridges AP. Postgrad Med J. 1976;52(3 suppl):9-17. Postgrad Med J. 1976. PMID: 785425 Review. No abstract available.